Patrick Yang

Dr. Patrick Y.
Yang is a Vice Chairman at National Resilience, Inc., an Independent Director at Sana Biotechnology, Inc., a Chairman, Chief Strategy Officer & Deputy GM at Acepodia, Inc., a Chairman at AbGenomics International, Inc. and a Chairman at AltruBio, Inc. He is on the Board of Directors at National Resilience, Inc., Sana Biotechnology, Inc., Antheia, Inc., Archigen Biotech Ltd., Aspen Sciences LLC, Polaris Group, Taiwania Capital Management USA, Inc. and Tetra Tech Tesoro, Inc. Dr. Yang was previously employed as an Executive Vice President by Juno Therapeutics, Inc., a Co-Founder by Acepodia Biotechnologies, Ltd., an Independent Director by Amyris, Inc., an Independent Director by Celladon Corp., an Independent Director by PharmaEssentia Corp., an Independent Director by Codexis, Inc., an Independent Director by Andeavor, an EVP & Head-Pharmaceutical Technical Operations by F.
Hoffmann-La Roche Ltd., an Executive Vice President-Product Operations by Genentech, Inc., a VP-Asia & Pacific Manufacturing Operations by Merck & Co., Inc., a Principal by General Electric Co., and a Principal by Life Systems, Inc. He also served on the board at TaiMed, Inc. and Polaris Pharmaceuticals, Inc. He received his undergraduate degree from National Chiao Tung University, a graduate degree from the University of Cincinnati (Ohio) and a doctorate degree from The Ohio State University.